Maternal serum fatty acid binding protein 4 (FABP4) and the development of preeclampsia

Journal of Clinical Endocrinology and Metabolism

Volumn 97, Issue 3, 2012, Pages

  Scifres, Christina M ^a   Catov, Janet M ^a   Simhan, Hyagriv ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FATTY ACID BINDING PROTEIN 4;

ADULT; ARTICLE; BODY MASS; CASE CONTROL STUDY; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; FIRST TRIMESTER PREGNANCY; GESTATIONAL AGE; HUMAN; MATERNAL HYPERTENSION; MATERNAL SERUM; NULLIPARA; PREECLAMPSIA; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; PROTEINURIA; RANDOM SAMPLE; SYSTOLIC BLOOD PRESSURE;

ADULT; BLOOD PRESSURE; BODY MASS INDEX; CASE-CONTROL STUDIES; FATTY ACID-BINDING PROTEINS; FEMALE; HUMANS; PARITY; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PROSPECTIVE STUDIES;

EID: 84858011088     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2011-2276     Document Type: Article

References (44)

1. Sibai B, Dekker G, Kupferminc M 2005 Pre-eclampsia. Lancet 365: 785-799 (Pubitemid 40311367)
2. Roberts JM, Bodnar LM, Patrick TE, Powers RW 2011 The role of obesity in preeclampsia. Pregnancy Hypertens 1:6-16
3. Kaaja R, Laivuori H, Laakso M, Tikkanen MJ, Ylikorkala O 1999 Evidence of a state of increased insulin resistance in preeclampsia. Metabolism 48:892-896 (Pubitemid 29310046)
4. Solomon CG, Seely EW 2001 Brief review: hypertension in pregnancy: a manifestation of the insulin resistance syndrome? Hypertension 37:232-239 (Pubitemid 32199080)
5. Hauth JC, Clifton RG, Roberts JM, Myatt L, Spong CY, Leveno KJ, Varner MW, Wapner RJ, Thorp Jr JM, Mercer BM, Peaceman AM, Ramin SM, Carpenter MW, Samuels P, Sciscione A, Tolosa JE, Saade G, Sorokin Y, Anderson GD 2011 Maternal insulin resistance and preeclampsia. Am J Obstet Gynecol 204:327.e1-e6
6. Bellamy L, Casas JP, Hingorani AD, Williams DJ 2007 Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis. BMJ 335:974
7. Magnussen EB, Vatten LJ, Smith GD, Romundstad PR 2009 Hypertensive disorders in pregnancy and subsequently measured cardiovascular risk factors. Obstet Gynecol 114:961-970
8. Levine RJ, Maynard SE, Qian C, Lim KH, England LJ, Yu KF, Schisterman EF, Thadhani R, Sachs BP, Epstein FH, Sibai BM, Sukhatme VP, Karumanchi SA 2004 Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med 350:672-683 (Pubitemid 38364626)
9. Levine RJ, Lam C, Qian C, Yu KF, Maynard SE, Sachs BP, Sibai BM, Epstein FH, Romero R, Thadhani R, Karumanchi SA 2006 Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. N Engl J Med 355:992-1005 (Pubitemid 44343543)
10. Venkatesha S, Toporsian M, Lam C, Hanai J, Mammoto T, Kim YM, Bdolah Y, Lim KH, Yuan HT, Libermann TA, Stillman IE, Roberts D, D'Amore PA, Epstein FH, Sellke FW, Romero R, Sukhatme VP, Letarte M, Karumanchi SA 2006 Soluble endoglin contributes to the pathogenesis of preeclampsia. Nat Med 12:642-649 (Pubitemid 43865232)
11. Conrad KP, Miles TM, Benyo DF 1998 Circulating levels of immunoreactive cytokines in women with preeclampsia. Am J Reprod Immunol 40:102-111
12. Bodnar LM, Ness RB, Markovic N, Roberts JM 2005 The risk of preeclampsia rises with increasing prepregnancy body mass index. Ann Epidemiol 15:475-482 (Pubitemid 40982122)
13. Furuhashi M, Hotamisligil GS 2008 Fatty acid-binding proteins: role in metabolic diseases and potential as drug targets. Nat Rev Drug Discov 7:489-503 (Pubitemid 351767117)
14. Scifres CM, Chen B, Nelson DM, Sadovsky Y 2011 Fatty acid binding protein 4 regulates intracellular lipid accumulation in human trophoblasts. J Clin Endocrinol Metab 96:E1083-E1091
15. Elmasri H, Karaaslan C, Teper Y, Ghelfi E, Weng M, Ince TA, Kozakewich H, Bischoff J, Cataltepe S 2009 Fatty acid binding protein 4 is a target of VEGF and a regulator of cell proliferation in endothelial cells. FASEB J 23:3865-3873
16. Xu A, Wang Y, Xu JY, Stejskal D, Tam S, Zhang J, Wat NM, Wong WK, Lam KS 2006 Adipocyte fatty acid-binding protein is a plasma biomarker closely associated with obesity and metabolic syndrome. Clin Chem 52:405-413
17. Xu A, Tso AW, Cheung BM, Wang Y, Wat NM, Fong CH, Yeung DC, Janus ED, Sham PC, Lam KS 2007 Circulating adipocyte-fatty acid binding protein levels predict the development of the metabolic syndrome: a 5-year prospective study. Circulation 115:1537-1543 (Pubitemid 46648638)
18. Yeung DC, Xu A, Cheung CW, Wat NM, Yau MH, Fong CH, Chau MT, Lam KS 2007 Serum adipocyte fatty acid-binding protein levels were independently associated with carotid atherosclerosis. Arterioscler Thromb Vasc Biol 27:1796-1802 (Pubitemid 47207176)
19. Fasshauer M, Seeger J, Waldeyer T, Schrey S, Ebert T, Kratzsch J, Lössner U, Blüher M, Stumvoll M, Faber R, Stepan H 2008 Serum levels of the adipokine adipocyte fatty acid-binding protein are increased in preeclampsia. Am J Hypertens 21:582-586 (Pubitemid 351589677)
20. 2002 ACOG practice bulletin. Diagnosis and management of preeclampsia and eclampsia. No. 33, January 2002. Obstet Gynecol 99:159-167
21. Miehle K, Stepan H, Fasshauer M 26 September 2011 Leptin, adiponectin, and other adipokines in gestational diabetes mellitus and preeclampsia. Clin Endocrinol (Oxf) doi: 10.1111/j.1365-2265.2011.04234
22. Schubring C, Englaro P, Siebler T, Blum WF, Demirakca T, Kratzsch J, Kiess W 1998 Longitudinal analysis of maternal serum leptin levels during pregnancy, at birth and up to six weeks after birth: relation to body mass index, skinfolds, sex steroids and umbilical cord blood leptin levels. Horm Res 50:276-283 (Pubitemid 29041362)
23. Catalano PM, Hoegh M, Minium J, Huston-Presley L, Bernard S, Kalhan S, Hauguel-De Mouzon S 2006 Adiponectin in human pregnancy: implications for regulation of glucose and lipid metabolism. Diabetologia 49:1677-1685 (Pubitemid 43848106)
24. Vahratian A, Misra VK, Trudeau S, Misra DP 2010 Prepregnancy body mass index and gestational age-dependent changes in lipid levels during pregnancy. Obstet Gynecol 116:107-113
25. Hotamisligil GS, Johnson RS, Distel RJ, Ellis R, Papaioannou VE, Spiegelman BM 1996 Uncoupling of obesity from insulin resistance through a targeted mutation in aP2, the adipocyte fatty acid binding protein. Science 274:1377-1379 (Pubitemid 26391462)
26. Uysal KT, Scheja L, Wiesbrock SM, Bonner-Weir S, Hotamisligil GS 2000 Improved glucose and lipid metabolism in genetically obese mice lacking aP2. Endocrinology 141:3388-3396 (Pubitemid 32269028)
27. Makowski L, Boord JB, Maeda K, Babaev VR, Uysal KT, Morgan MA, Parker RA, Suttles J, Fazio S, Hotamisligil GS, Linton MF 2001 Lack of macrophage fatty-acid-binding protein aP2 protects mice deficient in apolipoprotein E against atherosclerosis. Nat Med 7:699-705 (Pubitemid 32588026)
28. Boord JB, Maeda K, Makowski L, Babaev VR, Fazio S, Linton MF, Hotamisligil GS 2002 Adipocyte fatty acid-binding protein, aP2, alters late atherosclerotic lesion formation in severe hypercholesterolemia. Arterioscler Thromb Vasc Biol 22:1686-1691
29. Makowski L, Brittingham KC, Reynolds JM, Suttles J, Hotamisligil GS 2005 The fatty acid-binding protein, aP2, coordinates macrophage cholesterol trafficking and inflammatory activity. J Biol Chem 280:12888-12895
30. Furuhashi M, Tuncman G, Görgün CZ, Makowski L, Atsumi G, Vaillancourt E, Kono K, Babaev VR, Fazio S, Linton MF, Sulsky R, Robl JA, Parker RA, Hotamisligil GS 2007 Treatment of diabetes and atherosclerosis by inhibiting fatty-acid-binding protein aP2. Nature 447:959-965 (Pubitemid 46975747)
31. Tuncman G, Erbay E, Hom X, De Vivo I, Campos H, Rimm EB, Hotamisligil GS 2006 A genetic variant at the fatty acid-binding protein aP2 locus reduces the risk for hypertriglyceridemia, type 2 diabetes, and cardiovascular disease. Proc Natl Acad Sci USA 103: 6970-6975
32. Kralisch S, Stepan H, Kratzsch J, Verlohren M, Verlohren HJ, Drynda K, Lössner U, Blüher M, Stumvoll M, Fasshauer M 2009 Serum levels of adipocyte fatty acid binding protein are increased in gestational diabetes mellitus. Eur J Endocrinol 160:33-38
33. Joffe GM, Esterlitz JR, Levine RJ, Clemens JD, Ewell MG, Sibai BM, Catalano PM 1998 The relationship between abnormal glucose tolerance and hypertensive disorders of pregnancy in healthy nulliparous women. Calcium for Preeclampsia Prevention (CPEP) Study Group. Am J Obstet Gynecol 179:1032-1037 (Pubitemid 28489303)
34. Stejskal D, Karpisek M 2006 Adipocyte fatty acid binding protein in a Caucasian population: a new marker of metabolic syndrome? Eur J Clin Invest 36:621-625 (Pubitemid 44213828)
35. Haider DG, Schindler K, Bohdjalian A, Prager G, Luger A, Wolzt M, Ludvik B 2007 Plasma adipocyte and epidermal fatty acid binding protein is reduced after weight loss in obesity. Diabetes Obes Metab 9:761-763 (Pubitemid 47261860)
36. Fisher RM, Hoffstedt J, Hotamisligil GS, Thörne A, Rydén M 2002 Effects of obesity and weight loss on the expression of proteins involved in fatty acid metabolism inhumanadipose tissue. Int J Obes Relat Metab Disord 26:1379-1385 (Pubitemid 35221887)
37. Lamounier-Zepter V, Look C, Alvarez J, Christ T, Ravens U, Schunck WH, Ehrhart-Bornstein M, Bornstein SR, Morano I 2009 Adipocyte fatty acid-binding protein suppresses cardiomyocyte contraction: a new link between obesity and heart disease. Circ Res 105:326-334
38. Aragonès G, Ferré R, Lázaro I, Cabré A, Plana N, Merino J, Heras M, Girona J, Masana L 2010 Fatty acid-binding protein 4 is associated with endothelial dysfunction in patients with type 2 diabetes. Atherosclerosis 213:329-331
39. Yoo HJ, Kim S, Park MS, Choi HY, Yang SJ, Seo JA, Kim SG, Kim NH, Baik SH, Choi DS, Choi KM 2011 Serum adipocyte fatty acid-binding protein is associated independently with vascular inflammation: analysis with (18)F-fluorodeoxyglucose positron emission tomography. J Clin Endocrinol Metab 96:E488-E492
40. Myatt L, Webster RP 2009 Vascular biology of preeclampsia. J Thromb Haemost 7:375-384
41. Karumanchi SA, Maynard SE, Stillman IE, Epstein FH, Sukhatme VP 2005 Preeclampsia: a renal perspective. Kidney Int 67:2101-2113 (Pubitemid 41623372)
42. Miyoshi T, Onoue G, Hirohata A, Hirohata S, Usui S, Hina K, Kawamura H, Doi M, Kusano KF, Kusachi S, Ninomiya Y 2010 Serum adipocyte fatty acid-binding protein is independently associated with coronary atherosclerotic burden measured by intravascular ultrasound. Atherosclerosis 211:164-169
43. Bao Y, Lu Z, Zhou M, Li H, Wang Y, Gao M, Wei M, Jia W 2011 Serum levels of adipocyte fatty acid-binding protein are associated with the severity of coronary artery disease in Chinese women. PLoS One 6:e19115
44. Lykke JA, Langhoff-Roos J, Sibai BM, Funai EF, Triche EW, Paidas MJ 2009 Hypertensive pregnancy disorders and subsequent cardiovascular morbidity and type 2 diabetes mellitus in the mother. Hypertension 53:944-951